Skip to main content
Figure 1 | BMC Medicine

Figure 1

From: Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models

Figure 1

Human papillomavirus (HPV) prevalence and cervical cancer incidence from each model. Pre/post-vaccination HPV prevalence and cervical cancer incidence for type 16 and 18 HPV from each of the six models compared to figures in the standardised data set, for the hypothetical low-income country (top graph) and middle-income country (bottom graph). The Thai model shows HPV prevalence for all high-risk HPV types but cancer incidence for only type 16 and 18 related HPV infection.

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us